Caregiver Socio-Demographic Factors That Influence the Uptake of Third and Fourth Doses of Malaria Vaccine Among Under-Fives in Muhoroni Sub-County, Kenya

Malaria remains a leading cause of morbidity and mortality among children under five in sub-Saharan Africa, accounting for approximately 90% of childhood malaria deaths (WHO, 2023). The RTS, S/AS01E malaria vaccine, administered in four doses at 6, 7, 9, and 24 months, has shown moderate efficacy in reducing clinical and severe malaria (WHO, 2022). Despite promising outcomes, uptake of the third and fourth doses remains suboptimal in Kenya, particularly in high-burden areas such as Muhoroni Sub-County, where coverage drops from 72.1% for the first dose to 31.4% for the fourth dose (Okanda et al., 2023). Understanding sociodemographic factors that influence the poor uptake of third and fourth vaccine to dose uptake is critical for sustaining malaria prevention gains.
An analytical cross-sectional study employing mixed methods was conducted among 289 caregivers of children aged 9–60 months who had completed the first two doses of the malaria vaccine in Muhoroni Sub-County. Stratified random sampling was used to select participants. Quantitative data were collected via structured questionnaires and analysed using SPSS v27. Descriptive statistics summarized uptake patterns, while Chi-square tests and logistic regression identified predictors of third and fourth dose uptake at a 95% confidence interval. Qualitative data from key informant interviews were thematically analysed using NVivo software.
The uptake of the third dose was 50.9% (n=147), while only 10.4% (n=30) received the fourth dose. Higher caregiver education was significantly associated with third dose uptake (OR=1.27; 95% CI: 0.56–2.89; p=0.043). Greater distance to health facilities reduced the odds of third dose uptake by 81% (OR=0.19; 95% CI: 0.11–0.31; p<0.001). Cultural beliefs discouraging vaccination were negatively associated with uptake of the third dose (χ²=11.17; p=0.001), while the perception that children receive “too many vaccines” was linked to lower fourth dose uptake (χ²=4.17; p=0.041). Qualitative findings reinforced these results, highlighting logistical barriers, misinformation, and limited community engagement as key obstacles.
Third and fourth dose uptake of RTS, S/AS01E remains far below WHO targets in Muhoroni Sub-County. Education level, proximity to health services, and socio-cultural perceptions significantly influence uptake. Targeted strategies, including community-driven awareness campaigns, improved vaccine accessibility, and culturally sensitive health messaging, are essential to close the late-dose coverage gap and reduce malaria-related child mortality.

Malaria vaccine, RTS, S/AS01E, third dose, fourth dose, uptake, socio-demographic factors

1. Abdulkadir, B. I., & Ajayi, I. O. (2015). Willingness to accept malaria vaccine among caregivers of under-5 children in Ibadan North Local Government Area, Nigeria. https://doi.org/10.5281/ZENODO.10870005 [Google Scholar] [Crossref]

2. Acharya, P., Kismul, H., Mapatano, M.A. & Hatløy, A. (2019). Correction: Individual- and community-level determinants of child immunization in the Democratic Republic of Congo: A multilevel analysis. PloS One, 14(1). https://doi.org/10.1371/journal.pone.0211299 [Google Scholar] [Crossref]

3. Adeniji E, Asante KP, Boahen O, Compaor G, Coulibaly B, Kaali S, et al. Estimating Annual Fluctuations in Malaria Transmission Intensity and the Use of Malaria Control Interventions in Five Sub-Saharan African Countries. 2020;103(5):1883–92. [Google Scholar] [Crossref]

4. Amboko, B., Stepniewska, K., Macharia, P. M., Machini, B., Bejon, P., Snow, R. W., & Zurovac, D. (2020). Trends in health workers’ compliance with outpatient malaria case-management guidelines across malaria epidemiological zones in Kenya, 2010–2016. Malaria Journal, 19(1), 406. https://doi.org/10.1186/s12936-020-03479-z [Google Scholar] [Crossref]

5. Ateke, A. N., Dinga, J. N., Tchokfe, S., Amani, A., Madaina, I., Ticha, M. N. S., Abizou, M. B., Saidu, Y., Bachir, H. B., & Cleenewerck de Kiev, L. (2024). Malaria Vaccine Acceptance and Associated Factors in Cameroon. Available at SSRN 4712743. [Google Scholar] [Crossref]

6. Asmare, G. (2022). Willingness to accept malaria vaccine among caregivers of under-5 children in Southwest Ethiopia: A community based cross-sectional study. Malaria Journal, 21(1), 146. https://doi.org/10.1186/s12936-022-04164-z [Google Scholar] [Crossref]

7. Ballou, W. R. (2009). The development of the RTS,S malaria vaccine candidate: Challenges and lessons. Parasite Immunology, 31(9), 492–500. https://doi.org/10.1111/j.1365-3024.2009.01143.x [Google Scholar] [Crossref]

8. Barreaux, P., Barreaux, A. M., Sternberg, E. D., Suh, E., Waite, J. L., Whitehead, S. A., & Thomas, M. B. (2017). Priorities for broadening the malaria vector control tool kit. Trends in Parasitology, 33(10), 763–774. [Google Scholar] [Crossref]

9. Benin, A. L., Wisler-Scher, D. J., Colson, E., Shapiro, E. D., & Holmboe, E. S. (2006). Qualitative Analysis of Mothers’ Decision-Making About Vaccines for Infants: The Importance of Trust. Pediatrics, 117(5), 1532–1541. https://doi.org/10.1542/peds.2005-1728 [Google Scholar] [Crossref]

10. Bingham, A., Gaspar, F., Lancaster, K., Conjera, J., Collymore, Y., & Ba-Nguz, A. (2012). Community perceptions of malaria and vaccines in two districts of Mozambique. Malaria Journal, 11(1), 394. https://doi.org/10.1186/1475-2875-11-394 [Google Scholar] [Crossref]

11. Bonita, R., Beaglehole, R., & Kjellström, T. (2006). Basic epidemiology (2. ed). WHO. [Google Scholar] [Crossref]

12. Casares, S., Brumeanu, T.-D., & Richie, T. L. (2010). The RTS,S malaria vaccine. Vaccine, 28(31), 4880–4894. https://doi.org/10.1016/j.vaccine.2010.05.033 [Google Scholar] [Crossref]

13. Chen, Y., Gu, W., & He, B. (2022). Impact of a community-based health education intervention on awareness of influenza, pneumonia, and vaccination intention in chronic patients. Hum Vaccin Immunother 18:1–8. [Google Scholar] [Crossref]

14. Chepkiyeng Ezekiel, Alice Lakat, & Anselimo Makokha. (2023). Predictors of Malaria Vaccine Hesitancy Among Caregivers in Bumula Subcounty, Bungoma County. [Google Scholar] [Crossref]

15. Chukwuocha, U. M., Okorie, P. C., Iwuoha, G. N., Ibe, S. N., Dozie, I. N., & Nwoke, B. E. (2018). Awareness, perceptions and intent to comply with the prospective malaria vaccine in parts of South Eastern Nigeria. Malaria Journal, 17(1), 187. https://doi.org/10.1186/s12936-018-2335-0 [Google Scholar] [Crossref]

16. Cohen, L., Manion, L., & Morrison, K. (2017). Validity and reliability. In Research methods in education (pp. 245–284). Routledge. [Google Scholar] [Crossref]

17. Daniel, W., & Cross, C. (1999). Biostatistics: A foundation for analysis in the health sciences Wiley. New York. [Google Scholar] [Crossref]

18. Division of National Malaria Programme (DNMP) [Kenya] and ICF. (2012). Kenya Malaria Indicator Survey 2020. Nairobi, Kenya and Rockville, Maryland, USA: DNMP and ICF. [Google Scholar] [Crossref]

19. Durmaz, A., Dursun, İ., & Kabadayi, E. T. (2020). Mitigating the effects of social desirability bias in self-report surveys: Classical and new techniques. In Applied social science approaches to mixed methods research (pp. 146–185). IGI Global. [Google Scholar] [Crossref]

20. Elnour, Z., Grethe, H., Siddig, K., & Munga, S. (2023). Malaria control and elimination in Kenya: Economy-wide benefits and regional disparities. Malaria Journal, 22(1), 117. https://doi.org/10.1186/s12936-023-04505-6 [Google Scholar] [Crossref]

21. Feikin, D. R., Nguyen, L. M., Adazu, K., Ombok, M., Audi, A., Slutsker, L., & Lindblade, K. A. (2009). The impact of distance of residence from a peripheral health facility on pediatric health utilisation in rural western Kenya. Tropical Medicine & International Health, 14(1), 54–61. https://doi.org/10.1111/j.1365-3156.2008.02193.x [Google Scholar] [Crossref]

22. Fisher, A., Laing, J. and Stoeckel, J. (1998). Guidelines for overcoming design problems in Family planning operations research. In: Foreit. Family planning operations Research. New York. The Population Council. p. 345-55. [Google Scholar] [Crossref]

23. Fletcher, I. K., Grillet, M. E., Moreno, J. E., Drakeley, C., Hernández-Villena, J., Jones, K. E., & Lowe, R. (2022). Synergies between environmental degradation and climate variation on malaria re-emergence in southern Venezuela: A spatiotemporal modelling study.TheLancet Planetary Health, 6(9), e739–e748. https://doi.org/10.1016/S2542-5196(22)00192-9 [Google Scholar] [Crossref]

24. Fornace, K. M., Diaz, A. V., Lines, J., & Drakeley, C. J. (2021). Achieving global malaria eradication in changing landscapes. Malaria Journal, 20(1), 69. https://doi.org/10.1186/s12936-021-03599-0 [Google Scholar] [Crossref]

25. Frimpong, A., Kusi, K. A., Ofori, M. F., & Ndifon, W. (2018). Novel Strategies for Malaria Vaccine Design. Frontiers in Immunology, 9, 2769. https://doi.org/10.3389/fimmu.2018.02769 [Google Scholar] [Crossref]

26. Gachelin, G., Garner, P., Ferroni, E., Verhave, J. P., & Opinel, A. (2018). Evidence and strategies for malaria prevention and control: A historical analysis. Malaria Journal, 17, 1–18. [Google Scholar] [Crossref]

27. Galagali, P. M., Kinikar, A. A., & Kumar, V. S. (2022). Vaccine hesitancy: Obstacles and challenges. Current Pediatrics Reports, 10(4), 241–248. [Google Scholar] [Crossref]

28. Gilkey, M. B., Reiter, P. L., Magnus, B. E., McRee, A.-L., Dempsey, A. F., & Brewer, N. T. (2016). Validation of the vaccination confidence scale: A brief measure to identify parents at risk for refusing adolescent vaccines. Academic Pediatrics, 16(1), 42–49. [Google Scholar] [Crossref]

29. González-Sanz, M., Berzosa, P., & Norman, F. F. (2023). Updates on Malaria Epidemiology and Prevention Strategies. Current Infectious Disease Reports, 25(7), 131–139. https://doi.org/10.1007/s11908-023-00805-9 [Google Scholar] [Crossref]

30. Government of Kenya. (2007). Vision 2030 Kenya, Popular Version (2007). Government of the Republic of Kenya. [Google Scholar] [Crossref]

31. Grant, J., Gyan, T., Agbokey, F., Webster, J., Greenwood, B., & Asante, K. P. (2022). Challenges and lessons learned during the planning and early implementation of the RTS,S/AS01E malaria vaccine in three regions of Ghana: A qualitative study. Malaria Journal, 21(1), 147. https://doi.org/10.1186/s12936-022-04168-9 [Google Scholar] [Crossref]

32. Greenwood, B. (2017). Elimination of malaria: Halfway there. Transactions of the Royal Society of Tropical Medicine and Hygiene, 111(1), 1–2. [Google Scholar] [Crossref]

33. Gulliford, M. (Ed.). (2003). Access to health care. Routledge. [Google Scholar] [Crossref]

34. Hadjipanayis, A., van Esso, D., Del Torso, S., Dornbusch, H. J., Michailidou, K., Minicuci, N., Pancheva, R., Mujkic, A., Geitmann, K., & Syridou, G. (2020). Vaccine confidence among parents: Large scale study in eighteen European countries. Vaccine, 38(6), 1505–1512. [Google Scholar] [Crossref]

35. Hancock, G. R., Stapleton, L. M., & Mueller, R. O. (Eds.). (2019). The reviewer’s guide to quantitative methods in the social sciences (Second Edition). Routledge. [Google Scholar] [Crossref]

36. Hill, J., Bange, T., Hoyt, J., Kariuki, S., Jalloh, M. F., Webster, J., & Okello, G. (2024). Integration of the RTS,S/AS01 malaria vaccine into the Essential Programme on Immunisation in western Kenya: A qualitative longitudinal study from the health system perspective. The Lancet Global Health, 12(4), e672–e684. https://doi.org/10.1016/S2214-109X(24)00013-5 [Google Scholar] [Crossref]

37. Hoyt, J., Okello, G., Bange, T., Kariuki, S., Jalloh, M. F., Webster, J., & Hill, J. (2023). RTS,S/AS01 malaria vaccine pilot implementation in western Kenya: A qualitative longitudinal study to understand immunisation barriers and optimise uptake. BMC Public Health, 23(1), 2283. https://doi.org/10.1186/s12889-023-17194-2 [Google Scholar] [Crossref]

38. Isah, A., Nnadi, O. A., Obi, O. C., Nnadi, C. C., Isiogugu, O. N., & Ukoha-Kalu, B. O. (2023). Risk perception and hesitancy towards malaria vaccines among hospital pharmacists in southeast Nigeria: A cross-sectional study. International Journal of Health Promotion and Education, 1–14. https://doi.org/10.1080/14635240.2023.2251441 [Google Scholar] [Crossref]

39. Jenkins R, Omollo R, Ongecha M, et al. (2015). Prevalence of malaria parasites in adults and its determinants in malaria endemic area of Kisumu County,Kenya. Malar J;14:1–6. [Google Scholar] [Crossref]

40. Jones, R. T., Ant, T. H., Cameron, M. M., & Logan, J. G. (2021). Novel control strategies for mosquito-borne diseases. Philosophical Transactions of the Royal Society B, 376(1818), 20190802. 41(8), 1503–1512. https://doi.org/10.1016/j.vaccine.2023.01.060 [Google Scholar] [Crossref]

41. Kapesa A, Kweka EJ, Atieli H, Kamugisha E, Zhou G, Githeko AK, et al. (2017). Why some sites are responding better to anti-malarial interventions? A case study from western Kenya. Malaria Journal 16: 498. https://doi.org/10.1186/s12936-017-2145-9 PMID: 29284476 [Google Scholar] [Crossref]

42. Kempter, E., & Upadhayay, N. B. (2022). Uncovering the Role of Education in the Uptake of Preventive Measures against Malaria in the African Population. Universität Tübingen. https://doi.org/10.15496/PUBLIKATION-72149 [Google Scholar] [Crossref]

43. Kennedy, J. (2020). Vaccine hesitancy: A growing concern. Pediatric Drugs, 22(2), 105–111.Kothari, C., (2003). “Research Methodology, Methods and Techniques”, New Age International Limited, Published at Ansari Road; Daryanani, New Delhi India [Google Scholar] [Crossref]

44. Lacey, H., Jain, N., Sugimoto, M., Shimato, M., Reine, I., & Oria, K. (2023). Combating malaria in Kenya through collaborative population health education: A systematic review and pilot case study. Infectious Diseases, 55(10), 664–683. https://doi.org/10.1080/23744235.2023.2231082 [Google Scholar] [Crossref]

45. Leask, J. (2011). Target the fence-sitters. Nature, 473(7348), 443–445. https://doi.org/10.1038/473443a [Google Scholar] [Crossref]

46. Limaye, R. J., Opel, D. J., Dempsey, A., Ellingson, M., Spina, C., Omer, S. B., Dudley, M. Z., Salmon, D. A., & O’Leary, S. T. (2021). Communicating with vaccine-hesitant parents: A narrative review. Academic Pediatrics, 21(4), S24–S29. [Google Scholar] [Crossref]

47. Lorini, C., Santomauro, F., & Donzellini, M. (2018). Health literacy and vaccination: A systematic review. Hum Vaccin Immunother, 14, 478–488. [Google Scholar] [Crossref]

48. Maduka, O. (2018). End malaria for good: A review of current strategies and future novelties for malaria elimination in Nigeria. MalariaWorld Journal, 9. [Google Scholar] [Crossref]

49. Ministry of Health. (2012). National Policy Guidelines on Immunization. [Google Scholar] [Crossref]

50. Ministry of Health. (2013). Kenya Service Availability and Readiness Assessment Mapping (SARAM) Report. [Google Scholar] [Crossref]

51. Ministry of Health. (2014). Kenya Health Policy 2014–2030. [Google Scholar] [Crossref]

52. Ministry of Health. (2019). Kenya Malaria Strategy 2019–2023. [Google Scholar] [Crossref]

53. Mitiku, I., & Assefa, A. (2017). Caregivers’ perception of malaria and treatment-seeking behaviour for under five children in Mandura District, West Ethiopia: A cross-sectional study. Malaria Journal, 16, 1–10. [Google Scholar] [Crossref]

54. MoH. (2020, December). Kenya Progress Report on Health and Health-related SDGs. [Google Scholar] [Crossref]

55. MOH Kenya. (2020). Kenya Community Health Strategy 2020—2025. [Google Scholar] [Crossref]

56. Monguno, A. K. (2013). Socio Cultural and Geographical Determinants of Child Immunisation in Borno State, Nigeria. Journal of Public Health in Africa, 4(1), e10. https://doi.org/10.4081/jphia.2013.e10 [Google Scholar] [Crossref]

57. Motta, M., Callaghan, T., Sylvester, S., & Lunz-Trujillo, K. (2023). Identifying the prevalence, correlates, and policy consequences of anti-vaccine social identity. Politics, Groups, and Identities, 11(1), 108–122. https://doi.org/10.1080/21565503.2021.1932528 [Google Scholar] [Crossref]

58. Moturi, A. K., Jalang’o, R., Cherono, A., Muchiri, S. K., Snow, R. W., & Okiro, E. A. (2023). Malaria vaccine coverage estimation using age-eligible populations and service user denominators in Kenya. Malaria Journal, 22(1), 287. https://doi.org/10.1186/s12936-023-04721-0 [Google Scholar] [Crossref]

59. Moturi, A. K., Suiyanka, L., Mumo, E., Snow, R. W., Okiro, E. A., & Macharia, P. M. (2022). Geographic accessibility to public and private health facilities in Kenya in 2021: An updated geocoded inventory and spatial analysis. Frontiers in Public Health, 10, 1002975. https://doi.org/10.3389/fpubh.2022.1002975 [Google Scholar] [Crossref]

60. Mugenda and Mugenda, (2003); “Research Methods: Quantitative & Qualitative Approaches”; Acts Press; Nairobi. [Google Scholar] [Crossref]

61. Mumtaz, H., Nadeem, A., Bilal, W., Ansar, F., Saleem, S., Khan, Q. A., Tango, T., Farkouh, C., Belay, N. F., Verma, R., Farkouh, M., & Saqib, M. (2023). Acceptance, availability, and feasibility of RTS, S/AS01 malaria vaccine: A review. Immunity, Inflammation and Disease, 11(6), e899. https://doi.org/10.1002/iid3.899 [Google Scholar] [Crossref]

62. Mvundura, M., Lorenson, K., Chweya, A., Kigadye, R., Bartholomew, K., Makame, M., Lennon, T. P., Mwangi, S., Kirika, L., & Kamau, P. (2015). Estimating the costs of the vaccine supply chain and service delivery for selected districts in Kenya and Tanzania. Vaccine, 33(23), 2697–2703. [Google Scholar] [Crossref]

63. Mwingira, F. W., Matiya, D. J., & Chacky, F. (2024). Willingness and Perceptions of Malaria Vaccines among Caregivers in Dar es Salaam, Tanzania. https://doi.org/10.21203/rs.3.rs-4330328/v1 [Google Scholar] [Crossref]

64. NACOSTI. (2004). Guidelines for Ethical Conduct of Biomedical Research Involving Human Subjects in Kenya. [Google Scholar] [Crossref]

65. Naing, L., Winn, T., & Rusli, B. (2006). Practical issues in calculating the sample size for prevalence studies. Archives of Orofacial Sciences, 1, 9–14. [Google Scholar] [Crossref]

66. National Treasury. (2019). SDGs Status Report: Implementation of the Agenda 2030 for Sustainable Development in Kenya. [Google Scholar] [Crossref]

67. Novilla, M. L. B., Goates, M. C., Redelfs, A. H., Quenzer, M., Novilla, L. K. B., Leffler, T., Holt, C. A., Doria, R. B., Dang, M. T., & Hewitt, M. (2023). Why parents say no to having their children vaccinated against measles: A systematic review of the social determinants of parental perceptions on MMR vaccine hesitancy. Vaccines, 11(5), 926. [Google Scholar] [Crossref]

68. Nutbeam, D., & Muscat, D. M. (2021). Health promotion glossary 2021. Health Promotion International, 36(6), 1578–1598. [Google Scholar] [Crossref]

69. Nyarko SH, Cobblah A. (2014) Sociodemographic determinants of malaria among under-five children in Ghana. Malar Res Treat.;4:1–6. doi:10.1155/2014/ 304361 [Google Scholar] [Crossref]

70. Ogbonnia Egwu, C., Aloke, C., Chukwu, J., Agwu, A., Alum, E., Tsamesidis, I., M Aja, P., E Offor, C., & Ajuka Obasi, N. (2022). A world free of malaria: It is time for Africa to actively champion and take leadership of elimination and eradication strategies. African Health Sciences, 22(4), 627–640. https://doi.org/10.4314/ahs.v22i4.68 [Google Scholar] [Crossref]

71. Ojakaa, D. I., Jarvis, J. D., Matilu, M. I., & Thiam, S. (2014). Acceptance of a malaria vaccine by caregivers of sick children in Kenya. Malaria Journal, 13(1), 172. https://doi.org/10.1186/1475-2875-13-172 [Google Scholar] [Crossref]

72. Okanda, I., Okuto, E., Abuonji, E., Sadia, M., Owili, P., Lakati, A., & Ayodo, G. (2023). The RTS, S/AS01E Vaccine Uptake and Non-Compliance Risk to Malaria in Children 6-36 Months in Western Kenya. [Google Scholar] [Crossref]

73. Okesanya, O. J., Atewologun, F., Lucero-Prisno, D. E., Adigun, O. A., Oso, T. A., Manirambona, E., Olabode, N. O., Eshun, G., Agboola, A. O., & Okon, I. I. (2024). Bridging the gap to malaria vaccination in Africa: Challenges and opportunities. Journal of Medicine, Surgery, and Public Health, 2, 100059. https://doi.org/10.1016/j.glmedi.2024.100059 [Google Scholar] [Crossref]

74. Okumu, F., Gyapong, M., Casamitjana, N., Castro, M. C., Itoe, M. A., Okonofua, F., & Tanner, M. (2022). What Africa can do to accelerate and sustain progress against malaria. PLOS Global Public Health, 2(6), e0000262. https://doi.org/10.1371/journal.pgph.0000262 [Google Scholar] [Crossref]

75. Olson, O., Berry, C., & Kumar, N. (2020). Addressing parental vaccine hesitancy towards childhood vaccines in the United States: A systematic literature review of communication interventions and strategies. Vaccines, 8(4), 590. [Google Scholar] [Crossref]

76. Palache, A., Rockman, S., Taylor, B., Akcay, M., Billington, J. K., & Barbosa, P. (2021). Vaccine complacency and dose distribution inequities limit the benefits of seasonal influenza vaccination, despite a positive trend in use. Vaccine, 39(41), 6081–6087. [Google Scholar] [Crossref]

77. Paterson, P., Meurice, F., Stanberry, L. R., Glismann, S., Rosenthal, S. L., & Larson, H. J. (2016). Vaccine hesitancy and healthcare providers. Vaccine, 34(52), 6700–6706. https://doi.org/10.1016/j.vaccine.2016.10.042 [Google Scholar] [Crossref]

78. Praet N, Asante KP, Bozonnat MC, Akité EJ, Ansah PO, Baril L, et al.Assessing the safety, impact and effectiveness of RTS, S/AS01E malaria vaccine following its introduction in three sub-Saharan African countries: methodological approaches and study set-up. Malar J [Internet]. 2022;21(1):1–12. Available from: https://doi.org/10.1186/s12936-022-04144-3 [Google Scholar] [Crossref]

79. Puri, N., Coomes, E. A., Haghbayan, H., & Gunaratne, K. (2020). Social media and vaccine hesitancy: New updates for the era of COVID-19 and globalized infectious diseases. Human Vaccines & Immunotherapeutics, 16(11), 2586–2593. https://doi.org/10.1080/21645515.2020.1780846 [Google Scholar] [Crossref]

80. Rahman, K., Khan, S. U., Fahad, S., Chang, M. X., Abbas, A., Khan, W. U., Rahman, L., Haq, Z. U., Nabi, G., & Khan, D. (2019). Nano-biotechnology: A new approach to treat and prevent malaria. International Journal of Nanomedicine, 1401–1410. [Google Scholar] [Crossref]

81. Rts, S. C. T. P. (1015). Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: Final results of a phase 3, individually randomised, controlled trial. The Lancet, 386(9988), 31–45. https://doi.org/10.1016/S0140-6736(15)60721-8 [Google Scholar] [Crossref]

82. Savi, M. K., Pandey, B., Swain, A., Lim, J., Callo-Concha, D., Azondekon, G. R., Wahjib, M., & Borgemeister, C. (2024). Urbanization and malaria have a contextual relationship in endemic areas: A temporal and spatial study in Ghana. PLOS Global Public Health, 4(5), e0002871. https://doi.org/10.1371/journal.pgph.0002871 [Google Scholar] [Crossref]

83. Setia, M. S. (2016). Methodology series module 3: Cross-sectional studies. Indian Journal of Dermatology, 61(3), 261. [Google Scholar] [Crossref]

84. Shah, H. A., Carrasco, L. R., Hamlet, A., & Murray, K. A. (2022). Exploring agricultural land-use and childhood malaria associations in sub-Saharan Africa. Scientific Reports, 12(1), 4124. https://doi.org/10.1038/s41598-022-07837-6 [Google Scholar] [Crossref]

85. Shapiro, G. K., Tatar, O., Dube, E., Amsel, R., Knauper, B., Naz, A., Perez, S., & Rosberger, Z. (2018). The vaccine hesitancy scale: Psychometric properties and validation. Vaccine, 36(5), 660–667. [Google Scholar] [Crossref]

86. Shrestha, B., & Dunn, L. (2019). The declaration of Helsinki on medical research involving human subjects: A review of seventh revision. Journal of Nepal Health Research Council, 17(4), 548–552. [Google Scholar] [Crossref]

87. Siani, A. (2019). Measles outbreaks in Italy: A paradigm of the re-emergence of vaccine-preventable diseases in developed countries. Preventive Medicine, 121, 99–104. [Google Scholar] [Crossref]

88. Sicuri, E., Yaya Bocoum, F., Nonvignon, J., Alonso, S., Fakih, B., Bonsu, G., Kariuki, S., Leeuwenkamp, O., Munguambe, K., & Mrisho, M. (2019). The costs of implementing vaccination with the RTS, S malaria vaccine in five sub-Saharan African countries. MDM Policy & Practice, 4(2), 2381468319896280. [Google Scholar] [Crossref]

89. Siena, L. M., Isonne, C., & Sciurti, A. (2022). The Association of health literacy with intention to vaccinate and vaccination status: A systematic review. Vaccines (Basel, 10(1832). [Google Scholar] [Crossref]

90. Sossouhounto, S. L., Salibi, G., & Tzenios, N. (2024). Malaria in West Africa: Persistent Challenges and Innovative Eradication Strategies. Special Journal of the Medical Academy and Other Life Sciences., 2(3). [Google Scholar] [Crossref]

91. Strecher, V. J., & Rosenstock, I. M. (1997). The health belief model. Cambridge Handbook of Psychology, Health and Medicine, 113, 117. [Google Scholar] [Crossref]

92. Sulaiman Kabir., Isma’il Tsiga-Ahmed, F., Sale Musa, M., Kabir Sulaiman, A., Muhammad [Google Scholar] [Crossref]

93. Dayyab, F., Ab Khan, M., Idris Ahmad, S., Abasi-okot Akpan, U., Ibrahim Usman, U., & [Google Scholar] [Crossref]

94. Tjjani Bako, A. (2023). Prevalence, determinants, and reasons for malaria vaccine [Google Scholar] [Crossref]

95. hesitancy among caregivers of under-five children in Nigeria: Results from a nationwide [Google Scholar] [Crossref]

96. cross-sectional survey. Vaccine, [Google Scholar] [Crossref]

97. Sultana M, Sheikh N, Mahumud RA, Jahir T, Islam Z, Sarker AR. Prevalence and associated determinants of malaria parasites among Kenyan children. Trop Med Health. 2017;45(1):1–9. [Google Scholar] [Crossref]

98. Tabiri D, Ouédraogo JCRP, Nortey PA. Factors associated with malaria vaccine uptake in Sunyani [Google Scholar] [Crossref]

99. Municipality, Ghana. Malar J [Internet]. 2021;20(1):1–18. Available from: [Google Scholar] [Crossref]

100. https://doi.org/10.1186/s12936-021-03857-1 [Google Scholar] [Crossref]

101. Taylor, D., Bury, M., Campling, N., Carter, S., Garfied, S., Newbould, J., & Rennie, T. (2006). A Review of the use of the Health Belief Model (HBM), the Theory of Reasoned Action (TRA), the Theory of Planned Behaviour (TPB) and the Trans-Theoretical Model (TTM) to study and predict health related behaviour change. London, UK: National Institute for Health and Clinical Excellence, 1–215. [Google Scholar] [Crossref]

102. Tizifa, T. A., Kabaghe, A. N., McCann, R. S., van den Berg, H., Van Vugt, M., & Phiri, K. S. (2018). Prevention efforts for malaria. Current Tropical Medicine Reports, 5, 41–50. [Google Scholar] [Crossref]

103. Verger, P., & Dubé, E. (2020). Restoring confidence in vaccines in the COVID-19 era. Expert Review of Vaccines, 19(11), 991–993. [Google Scholar] [Crossref]

104. Verma, R., Verma, S., & Abhishek, K. (2024). Research Methodology. Booksclinic Publishing. [Google Scholar] [Crossref]

105. Watts, C., Atieli, H., Alacapa, J., Lee, M.-C., Zhou, G., Githeko, A., Yan, G., & Wiseman, V. (2021). Rethinking the economic costs of hospitalization for malaria: Accounting for the comorbidities of malaria patients in western Kenya. Malaria Journal, 20, 1–9. [Google Scholar] [Crossref]

106. WHO. (2013). WHO informal consultation on fever management in peripheral health care settings: A global review of evidence and practice. WHO. https://iris.who.int/handle/10665/95116 [Google Scholar] [Crossref]

107. WHO. (2014). Strategic Advisory Group of Experts on Immunization (SAGE). https://www.who.int/groups/strategic-advisory-group-of-experts-on-immunization/working-groups/vaccine-hesitancy-(march-2012-to-november-2014) [Google Scholar] [Crossref]

108. World Health Organization. (2018). First malaria vaccine in Africa: A potential new tool for child health and improved malaria control (p. 4 p.) [Technical documents]. World Health Organization. [Google Scholar] [Crossref]

109. WHO. (2019). Health emergencies in Europe: Making sure every country is ready. WHO. Regional Office for Europe. [Google Scholar] [Crossref]

110. WHO. (2022). Malaria: The malaria vaccine implementation programme (MVIP). [Google Scholar] [Crossref]

111. WHO. (2023). World malaria report 2023. WHO. [Google Scholar] [Crossref]

112. Xiang, L., Yoon, S., Low, A. H. L., Leung, Y. Y., Fong, W., Lau, T. C., Koh, D. R., & Thumboo, J. (2022). Approaches to improving symptom appraisal: A systematic literature review. BMJ Open, 12(8), e064521. https://doi.org/10.1136/bmjopen-2022-064521 [Google Scholar] [Crossref]

113. Yang, L., Grenfell, B. T., & Mina, M. J. (2020). Waning immunity and re-emergence of measles and mumps in the vaccine era. Current Opinion in Virology, 40, 48–54. [Google Scholar] [Crossref]

114. Yeboah, D., Owusu-Marfo, J., & Agyeman, Y. N. (2022). Predictors of malaria vaccine uptake among children 6–24 months in the Kassena Nankana Municipality in the Upper East Region of Ghana. Malaria Journal, 21(1), 339. https://doi.org/10.1186/s12936-022-04378-1 [Google Scholar] [Crossref]

115. Zavala F. RTS, S: the first malaria vaccine. J Clin Invest. 2022;132(1). [Google Scholar] [Crossref]

116. Zhou, G., Githure, J., Lee, M.-C., Zhong, D., Wang, X., Atieli, H., Githeko, A. K., Kazura, J., & Yan, G. (2024). Malaria transmission heterogeneity in different eco-epidemiological areas of western Kenya: A region-wide observational and risk classification study for adaptive intervention planning. Malaria Journal, 23(1), 74. https://doi.org/10.1186/s12936-024-04903-4 [Google Scholar] [Crossref]

• Tribal Child Nutrition and Health in District of Sundargarh: A Public Health Review of ICDS Intervention
• Knowledge, Attitudes and Practices Towards Prostate Cancer Screening Amongst Men Aged 40-60 Years in The Buea Health District: A Cross-Sectional Study
• Compliance with JCI Protocols: A Focus on Employee Safety
• Influence and Involvement of Teachers in Menstrual Hygiene Management of Female Secondary School Students in Kogi State, Nigeria
• A Critical Evaluation of Ayushman Bharat Pradhan Mantri Jan Arogya Yojana in Bihar